Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MB-PDT vs Amorolfine for Toenail Onychomycosis in Asians
NCT03098342Completed
- Sponsor
- Chulalongkorn University
- Start
- Jun 2017
- Primary completion
- Dec 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, single-blind trial of methylene blue in onychomycosis (2 arms), sponsored by Chulalongkorn University. Primary endpoint: Onychomycosis severity index at 18 months. Started Jun 2017; status: completed.
02
Drugs
methylene blue
03
Conditions
onychomycosis
Beyond the preview
Go deeper on NCT03098342.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03098342.